Psychopharmacology and Psychiatry Updates

Faculty: Robert Hudak, M.D.
Host: Flavio Guzmán, M.D.
Learn more about our memberships here
Earn 1.25 CME: Treatment-Resistant OCD: From SSRIs to Augmentation
Glutamatergic Augmentation in OCD: Memantine, Riluzole, Lamotrigine and Other Agents

Faculty: Oliver Freudenreich, M.D.
Host: Flavio Guzmán, M.D.
Learn more about our memberships here
Earn 0.75 CMEs: Quick Take Vol. 85
Schizophrenia: Which of Seven Antipsychotics Wins on Acute Efficacy and Safety?

Faculty: Robert Hudak, M.D.
Host: Flavio Guzmán, M.D.
Learn more about our memberships here
Earn 1.25 CME: SSRI Dosing for OCD: Beyond FDA Guidelines
Treatment-Resistant OCD: From SSRIs to Augmentation

In this episode, we explore a new meta-analysis reconciling trazodone's real-world reputation with cautious sleep medicine guidelines, examining its effects on sleep architecture and depressive symptoms in patients with comorbid insomnia and depression, alongside its notable side effect profile. Can a decades-old antidepressant be the missing link for restorative sleep? 
Faculty: Paul Zarkowski, M.D.
Host: Flavio Guzmán, M.D.
Learn more about our memberships here
Earn 0.5 CMEs: Quick Take Vol. 85
Trazodone for Insomnia and Comorbid Depression: Are the AASM Guidelines Relevant?

In this episode, we explore why antipsychotics cause hyperprolactinemia and sexual side effects, a leading reason patients quietly stop treatment. Dr. Oliver Freudenreich breaks down which medications carry the highest risk, the long-term health implications, and practical strategies for monitoring, switching, or augmenting therapy.
Faculty: Oliver Freudenreich, M.D., F.A.C.L.P.
Host: Richard Seeber, M.D.
Learn more about our memberships here
Earn 1.25 CME: Managing Side Effects of Antipsychotics: What Every Psychiatrist Should Know
Managing Hyperprolactinemia and Sexual Side Effects from Antipsychotic Use